Advertisement

Topics

Biotechnologiepark Luckenwalde GmbH Company Profile

00:14 EST 19th December 2018 | BioPortfolio

The Biotechnology Park Luckenwalde lies about 30 miles south from the Berlin city centre. The excellent connections to roads, rail and to the Berlin airports ensures easy accessibility. The 22.000 inhabitants of the district town of the district of Teltow-Flaeming offers an excellent infrastructure in education, healthcare, culture and living conditions as ideal basic frame work. In the 70 acre park-like area new and established biotechnical firms come together under unrivalled conditions. The concept of the project guarantees a direct proximity of research working and living functions in a delightful recreational countryside, which is rich in water and forest.

The Biotechnology Park Luckenwalde serves the development of small and medium sized biotechnological firms, their suppliers and their service providers. The project offers both new founded and outsourced and already existing companies the best conditions in the Berlin/Potsdam area. This focus makes the location, even for large firms in the branch, very interesting. Groupings of this type are capable of generating synergies of high quality and effectiveness.

Conceptually the park integrates the following functional areas on a campus:


Incubator Technology and Innovation Center
CommunicationCenter
Building Moduls
Industrial sites
Residence
Co-operation network with R & D

Location

Im Biotechnologiepark, TGZ
Luckenwalde
Luckenwalde
14943
Germany

Contact

Phone: 49 33 71 / 6 81-1 00
Fax: 49 33 71 / 6 81-1 05
Email: bio-luck@bio-luck.de


News Articles [157 Associated News Articles listed on BioPortfolio]

New financing round at oncgnostics GmbH close

The life sciences company oncgnostics GmbH was able to double its investment of 750,000 euros following the very rapid and successful completion of its second crowd investing campaign on Seedmatch. A...

Royalties under patent licence agreements: can they remain payable even if the licensed patents(s) are revoked or not practised? Lessons from Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH

Précis In its recent decision in Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH (7 July 2016), the Court of Justice of the EU (“CJEU”) has ruled that an obligati...

Laufende Fusionskontrollverfahren: Bruker Daltonik GmbH, Bremen (D); Erwerb einer Mehrheitsbeteiligung von 80% an der HAIN LIFESCIENCE GmbH, Nehren (D);

Datum der Anmeldung:28.08.2018Aktenzeichen:B3-128/18Unternehmen:Bruker Daltonik GmbH, Bremen (D); Erwerb einer Mehrheitsbeteiligung von 80% an der HAIN LIFESCIENCE GmbH, Nehren (D);Produktmärkte:in.....

Laufende Fusionskontrollverfahren: The Paragon Fund II GmbH & Co. KG, München (D); mittelbarer Erwerb von mindestens 99% der Anteile sowie der Kontrolle über die UCB Innere Medizin GmbH & Co. KG, Monheim (D) und die UCB Primary Care GmbH, Monheim (D);

Datum der Anmeldung:07.08.2018Aktenzeichen:B3-119/18Unternehmen:The Paragon Fund II GmbH & Co. KG, München (D); mittelbarer Erwerb von mindestens 99% der Anteile sowie der Kontrolle über die UCB In....

Original-Research: CO.DON AG (von Sphene Capital GmbH): Buy

Original-Research: CO.DON AG - von Sphene Capital GmbH Einstufung von Sphene Capital GmbH zu CO.DON AG Unternehmen: CO.DON AG ISIN: DE000A1K0227 Anlass der Studie: Update Report Empfehlung: Buy se...

JA Solar dodáva poločlánkové moduly pre solárne elektrárne v Afrike

Spolutvorcami projektu v Namíbii sú renomovaný nemecký developer SunEQ GmbH, sesterská spoločnosť konzultačnej firmy pre obnoviteľné zdroje energie Suntrace GmbH a popredný nový dodáva...

Printing Ink is Hotter than Lava Flow

NewsPaul Leibinger GmbH & Co. KG has introduced a pigment ink to the market, which allows a clear typeface even at 1000° C. Particles are also kept in suspension through chemical stabilization.

Original-Research: Paion AG (von First Berlin Equity Research GmbH): Kaufen

Dow Jones received a payment from EQS/DGAP to publish this press release. Original-Research: Paion AG - von First Berlin Equity Research GmbH Einstufung von First Berlin Equity Research GmbH zu Pa...

PubMed Articles [12 Associated PubMed Articles listed on BioPortfolio]

A comparison of different farrowing systems - Part 1: Effects on the activity of the sow.

The aim of this study was to determine whether a 3-axis accelerometer (MSR 145B V5.106, MSR Electronics GmbH, Seuzach, Switzerland) can continuously record and display the activity behaviour of sows o...

A purpose-designed monofilament-fibre pad for debridement of hard-to-reach wounds: experience in clinical practice.

Effective and comfortable debridement is an important part of managing complex wounds. This user test evaluated a monofilament-fibre pad (with handle) (Debrisoft Lolly, Lohmann & Rauscher GmbH & Co. K...

Field study on loose farrowing in cold barns.

The aim of this field study was to examine the loose farrowing system in view of practicability, particularly to monitor piglet losses and their causes, on a farm proceeding in accordance with the BIO...

Evaluation of the real-world impact of rotational thromboelastometry-guided transfusion protocol in patients undergoing proximal aortic surgery.

Complex aortic procedures are potentially associated with important blood loss and coagulopathy. The aim of this study was to assess the impact of rotational thromboelastometry (ROTEM, Tem Internation...

Evaluation of Physicochemical Properties of New Calcium Silicate-Based Sealer.

This study aimed to evaluate the physicochemical properties of a calcium silicate-based sealer (Sealer Plus BC; MK Life, Porto Alegre, Brazil) compared with an epoxy-resin sealer (AH Plus; Dentsply De...

Clinical Trials [49 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

XC8 in the Treatment of Patients With Bronchial Asthma

A multicenter, double-blind, randomized, parallel-group comparative Phase II clinical study to assess the efficacy and safety of different doses of XC8 vs Placebo in patients with partly c...

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

User Performance Evaluation of Contour® Plus One, Accu-Chek® Performa Connect, FreeStyle Optium Neo and OneTouch® Select Plus Blood Glucose Monitoring Systems Following ISO 15197:2013; EN ISO 15197:2015

The user performance evaluation shows whether people with diabetes are able to obtain accurate measurement results with a blood glucose monitoring system. In this study, user performance e...

Telemedical Examination of a Three-Component Oculomotor Testing Battery

The study investigates the feasibility and safety of the telemedical implementation of three diagnostic oculomotor tests using a video-oculography device and an extended teleconferencing s...

Companies [534 Associated Companies listed on BioPortfolio]

Biotechnologiepark Luckenwalde GmbH

The Biotechnology Park Luckenwalde lies about 30 miles south from the Berlin city centre. The excellent connections to roads, rail and to the Berlin airports ensures easy accessibility. The 22.000 inh...

Chemie-Kontor GmbH

Chemie-Kontor GmbH trades with chemical specialities for customers in Pharma-, Agro-, Cosmetics and Nutrition Industries and offers a broad range of services. Chemie-Kontor GmbH is agent for: Amberger...

OctreoPharm Sciences GmbH

OctreoPharm Sciences GmbH, located in Berlin (Germany) is a privately held clinical development company focusing on radiopharmaceuticals for the diagnosis and therapeutic control ...

Praher Beteiligungs GmbH

The vision of the company founder Ludwig Praher to produce better and better products of high-grade plastics was the basis for sound growth. Under the direction of Ing. Winfried Praher and Ewald Prahe...

Ormecon GmbH

Ormecon GmbH, with its location in Ammersbek/Germany, is the headquarter of Ormecon International. Ormecon GmbH was originally founded as "Ormecon Chemie GmbH & Co. KG" in 1996, as a 100% subsidiary o...

More Information about "Biotechnologiepark Luckenwalde GmbH" on BioPortfolio

We have published hundreds of Biotechnologiepark Luckenwalde GmbH news stories on BioPortfolio along with dozens of Biotechnologiepark Luckenwalde GmbH Clinical Trials and PubMed Articles about Biotechnologiepark Luckenwalde GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Biotechnologiepark Luckenwalde GmbH Companies in our database. You can also find out about relevant Biotechnologiepark Luckenwalde GmbH Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...


Corporate Database Quicklinks



Searches Linking to this Company Record